See also this year's filing and all EDGAR filings for this company.
PDF Report 0001623526_2023_Stoke_Therapeutics_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001623526, Stoke Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 244,070,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 6,675,000 |
3 | remainder_Assets | 5,322,000 |
4 | LiabilitiesCurrent | 31,394,000 |
5 | LiabilitiesNoncurrent | 39,824,000 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 38,924,000 |
9 | ResearchAndDevelopmentExpense | 77,837,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 12,405,000 |
12 | remainder_NetIncome | 3,289,000 |
13 | remainder_ComprehensiveNetIncome | -1,007,000 |
yvar | yval | |
---|---|---|
0 | Assets | 256,067,000 |
1 | Liabilities | 71,218,000 |
2 | Expenses | 116,761,000 |
3 | Revenues | 12,405,000 |
4 | StockholdersEquity | 184,849,000 |
5 | NetIncome | -101,067,000 |
6 | ComprehensiveNetIncome | -101,570,500 |
7 | BaseVar | 230,373,500 |
8 | EconomicCapitalRatio | 1.32 |